Retroperitoneal lymph node dissection for testis cancer: a comparison between open and robot-assisted approach in oncological and surgical outcomes
European Journal of Surgical Oncology · 2025
DOI: 10.1016/j.ejso.2025.110281 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Elena Lievore und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy. Hauptthemen laut MEDLINE: Testicular Neoplasms, Lymph Node Excision, Robotic Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Retroperitoneal lymph node dissection (RPLND) is an integral part of the multidisciplinary treatment of Testis cancer (TC). Up to now, only few studies compared traditional open RPLND (O-RPLND) with minimally invasive approach. We investigated surgical outcomes and complication rates of patient with TC treated with O-RPLND or robot assisted (RA-RPLND). MATERIALS AND METHODS: We performed a retrospective analysis of all consecutive patients who underwent RPLND for TC, between 2001 and 2023. We recorded Patient demographics, perioperative and post-operative data. Descriptive statistics depicted differences between O-RPLND and RA-RPLND. Multivariable Poisson regression models (MPRMs) tested for predictors of surgical drain permanence, NSAIDs use (days), LOS, EBL and OT. Multivariable logistic regression models (MLRM) tested for of post operative complications. RESULTS: Of 144 patients who underwent RPLND, 53 (36.4 %) were treated with RA-RPLND and 91 (63.6 %) with O-RPLND. RA-RPLND group had significantly lower median EBL (50 ml vs 150 ml in O- RPLND; p < 0.01), median LOS (4 days vs 5.5 days in O-RPLND; p < 0.01), median drain indwelling days (4 vs 5 in O-RPLND; p = 0.03), Hb drop (1.5 g/dl vs 1.9 g/dl; p = 0.02) and median NSAIDs use (1 day vs 3 days in O-RPLND; p < 0.01). No difference in intra- and postoperative complication rates was recorded. In MPRM, RA-RPLND was associated with shorter LOS (RR:0.28; p < 0.01), drain permanence time (RR: 0.83; p = 0.01), NSAIDs use (RR:0.63; p < 0.01), and OT (RR 0.85; p < 0.01). CONCLUSION: RA-RPLND appears to lead to shorter LOS and permanence of surgical drain, lower need for painkillers, lower blood loss and lower OT to O-RPLND, but does not seem associated with lower complication rates compared to O-RPLND. Our findings require prospective validation in future randomized trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
- Department of Urology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122, Milan, Italy. Electronic address: f…
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122, Milan, Italy; Department of Radiology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122, Milan, Italy; Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, 20139, Milan, Italy.
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122, Milan, Italy; Department of Nuclear Medicine, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, 20122, Milan, Italy; Department of Pathology, IEO European Institute of Oncology, IRCCS, Via Ripamonti 435, Milan, Italy.
Zitieren
APA
Lievore, E., Mistretta, F. A., Piccinelli, M. L., Vaccaro, C., Tallini, M., Tozzi, M., Brescia, A., Bottero, D., Depalma, M., Petralia, G., Marvaso, G., Ceci, F., Fusco, N., Nolè, F., Jereczek-Fossa, B. A., Orsi, F., Luzzago, S., & Musi, G. (2025). Retroperitoneal lymph node dissection for testis cancer: a comparison between open and robot-assisted approach in oncological and surgical outcomes. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110281
Vancouver
Lievore E, Mistretta FA, Piccinelli ML, Vaccaro C, Tallini M, Tozzi M, et al. Retroperitoneal lymph node dissection for testis cancer: a comparison between open and robot-assisted approach in oncological and surgical outcomes. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110281
BibTeX
@article{Lievore2025,
author = {Lievore, Elena and Mistretta, Francesco Alessandro and Piccinelli, Mattia Luca and Vaccaro, Chiara and Tallini, Matteo and Tozzi, Marco and Brescia, Antonio and Bottero, Danilo and Depalma, Massimilano and Petralia, Giuseppe and Marvaso, Giulia and Ceci, Francesco and Fusco, Nicola and Nolè, Franco and Jereczek-Fossa, Barbara Alicja and Orsi, Franco and Luzzago, Stefano and Musi, Gennaro},
title = {Retroperitoneal lymph node dissection for testis cancer: a comparison between open and robot-assisted approach in oncological and surgical outcomes},
journal = {European Journal of Surgical Oncology},
year = {2025},
doi = {10.1016/j.ejso.2025.110281}
}
EUVIMED